Editorial Open Access
Volume 2 | Issue 2 | DOI: https://doi.org/10.33696/dentistry.2.014
Photodynamic Therapy for the Prevention of SARS-CoV-2 Infection in Dental Office: Could be Possible?
Cinzia Casu1,*
- 1DDS, Private Dental Practice, Cagliari, Italy
Corresponding Author
Cinzia Casu, ginzia.85@hotmail.it
Received Date: September 17, 2020
Accepted Date: October 29, 2020
Casu C. Photodynamic Therapy for the Prevention of SARS-CoV-2 Infection in Dental Office: Could be Possible?. Arch Dent. 2020; 2(2):44-46.
Copyright: © 2020 Casu C. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords
SARS-CoV-2 in dentistry, Photodynamic therapy, PDT for SARS-CoV-2, Methylen Blue for SARSCoV- 2
Recommended Articles
Susceptibility of Malignant Brain Tumors to 5-aminolaevulinic Acid Mediated Photodynamic Therapy: Direct Phototoxicity and Immunological Effects
Recently we published the article ‘Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment’.
Photodynamic Therapy for the Prevention of SARS-CoV-2 Infection in Dental Office: Could be Possible?
In January 2020, the World Health Organization (WHO) identified a novel coronavirus SARS-CoV-2 in the Wuhan province of China, which has since caused a worldwide pandemic, with more than 21.2 million confirmed cases and over 760,200 confirmed deaths as of 14 August 2020. SARS-CoV-2 is a single-stranded RNA virus classified in
Microbial Resistance to Photodynamic Therapy
Microbial resistance to antibiotics has become a major area of research given that it caused 1.27 million human deaths in 2019. Methicillin-resistant staphylococcus aureus (MRSA) accounted for half these deaths, and lower respiratory infection is the most burdensome syndrome.